Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Alector
(NASDAQ:ALEC)
Intraday
$5.10
0.01
[0.20%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$5.10
0.01
[0.20%]
Last update: 11:50AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Alector Stock (NASDAQ:ALEC)
Alector Stock (NASDAQ: ALEC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 28, 2024
HC Wainwright & Co. Reiterates Buy on Alector, Maintains $41 Price Target
Benzinga Newsdesk
-
Feb 28, 2024, 12:11PM
Tuesday, February 27, 2024
Alector Sees 2024 Collaboration Revenue $60M-$70M, Total R&D Expenses $210M-$230M
Benzinga Newsdesk
-
Feb 27, 2024, 5:04PM
Recap: Alector Q4 Earnings
Benzinga Insights
-
Feb 27, 2024, 4:50PM
Alector Q4 2023 GAAP EPS $(0.49) Beats $(0.77) Estimate, Sales $15.19M Beat $9.64M Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 4:46PM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Earnings Outlook For Alector
Benzinga Insights
-
Feb 26, 2024, 11:01AM
Thursday, February 08, 2024
Alector And GSK Have Announced To Dose The First Patient In PROGRESS-AD Phase 2 Trial Of AL101/GSK4527226 In Patients With Early Alzheimer's Disease
Benzinga Newsdesk
-
Feb 8, 2024, 7:09AM
Wednesday, February 07, 2024
The FDA Has Granted Breakthrough Therapy Designation To Alector/GSK's Latozinemab, An Investigational Human Monoclonal Antibody Designed To Block Sortilin To Elevate Progranulin Levels For To Treat Frontotemporal Dementia With A Progranulin Gene Mutation
Benzinga Newsdesk
-
Feb 7, 2024, 7:12AM
Wednesday, January 17, 2024
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 17, 2024, 1:12PM
Why Alector (ALEC) Stock Is Diving Today
Henry Khederian
-
Jan 17, 2024, 12:07PM
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
-
Jan 17, 2024, 11:18AM
Alector shares are trading lower after the company announced the pricing of a $75 million public offering of 10,869,566 shares of common stock.
Benzinga Newsdesk
-
Jan 17, 2024, 10:21AM
Alector Announces Pricing Of $75M Public Offering Of 10,869,566 Shares Of Common Stock
Benzinga Newsdesk
-
Jan 17, 2024, 8:58AM
Tuesday, January 16, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 16, 2024, 4:31PM
Alector Announces Proposed Public Offering Of Common Stock; Size And Terms Not Disclosed
Benzinga Newsdesk
-
Jan 16, 2024, 4:03PM
Friday, December 15, 2023
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Dec 15, 2023, 10:21AM
Thursday, December 14, 2023
Alector Upgraded, Analyst Sees High Reward Potential Ahead of Alzheimer's Disease Candidate's Phase 2 Results
Vandana Singh
-
Dec 14, 2023, 1:29PM
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 14, 2023, 12:56PM
Alector shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $8 to $15.
Benzinga Newsdesk
-
Dec 14, 2023, 10:15AM
Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Dec 14, 2023, 10:15AM
Harmonic To Rally Over 80%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
-
Dec 14, 2023, 7:57AM
Stifel Upgrades Alector to Buy, Raises Price Target to $15
Benzinga Newsdesk
-
Dec 14, 2023, 5:02AM
Tuesday, December 12, 2023
Expert Ratings for Alector
Benzinga Insights
-
Dec 12, 2023, 8:01AM
Deutsche Bank Initiates Coverage On Alector with Buy Rating, Announces Price Target of $12
Benzinga Newsdesk
-
Dec 12, 2023, 4:55AM
Friday, November 17, 2023
Mizuho Maintains Buy on Alector, Lowers Price Target to $9
Benzinga Newsdesk
-
Nov 17, 2023, 12:28PM
Tuesday, November 14, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Nov 14, 2023, 12:31PM
Monday, November 13, 2023
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Nov 13, 2023, 1:08PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Nov 13, 2023, 12:31PM
Tuesday, November 07, 2023
Alector Q3 EPS $(0.53) Beats $(0.66) Estimate, Sales $9.11M Miss $9.97M Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 5:11PM
Friday, October 27, 2023
Alector Announces Achievement Of Target Enrollment In Pivotal INFRONT-3 Phase 3 Clinical Trial Of Latozinemab In Individuals With Frontotemporal Dementia Due To A Progranulin Gene Mutation (FTD-GRN)
Benzinga Newsdesk
-
Oct 27, 2023, 7:02AM
Monday, September 25, 2023
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Sep 25, 2023, 1:04PM
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Benzinga Insights
-
Sep 25, 2023, 11:00AM
Alector shares are trading lower after Goldman Sachs initiated coverage on the stock with a Sell rating and $4 price target.
Benzinga Newsdesk
-
Sep 25, 2023, 9:10AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Sep 25, 2023, 9:06AM
Goldman Sachs Initiates Coverage On Alector with Sell Rating, Announces Price Target of $4
Benzinga Newsdesk
-
Sep 25, 2023, 5:02AM
Friday, September 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Benzinga Insights
-
Sep 22, 2023, 11:00AM
Alibaba, Standard Lithium, Anterix And Other Big Stocks Moving Higher On Friday
Lisa Levin
-
Sep 22, 2023, 10:45AM
Analyst Expectations for Alector's Future
Benzinga Insights
-
Sep 22, 2023, 8:01AM
Cantor Fitzgerald Initiates Coverage On Alector with Overweight Rating, Announces Price Target of $13
Benzinga Newsdesk
-
Sep 22, 2023, 7:26AM
Thursday, September 14, 2023
10% Owner of Alector Sold $3.00M In Stock
Benzinga Insights
-
Sep 14, 2023, 11:06AM
Thursday, September 07, 2023
Alector Announces Completion Of Enrollment In INVOKE-2 Phase 2 Clinical Trial Of AL002, A TREM2 Monoclonal Antibody, In Individuals With Early Alzheimer's Disease
Benzinga Newsdesk
-
Sep 7, 2023, 7:16AM
Tuesday, September 05, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 5, 2023, 1:34PM
Tuesday, August 29, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 29, 2023, 2:37PM
Friday, August 11, 2023
Expert Ratings for Alector
Benzinga Insights
-
Aug 11, 2023, 9:00AM
Mizuho Maintains Buy on Alector, Lowers Price Target to $10
Benzinga Newsdesk
-
Aug 11, 2023, 8:07AM
Tuesday, August 08, 2023
Stifel Maintains Hold on Alector, Lowers Price Target to $8
Benzinga Newsdesk
-
Aug 8, 2023, 11:09AM
Monday, August 07, 2023
Morgan Stanley Reiterates Equal-Weight on Alector, Maintains $10 Price Target
Benzinga Newsdesk
-
Aug 7, 2023, 10:46AM
Friday, August 04, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Aug 4, 2023, 1:31PM
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Aug 4, 2023, 12:55PM
Alector shares are trading higher after the company reported Q2 financial results and increased 2023 collaboration revenue outlook.
Benzinga Newsdesk
-
Aug 4, 2023, 11:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch